» Articles » PMID: 20052659

Placental Growth Factor in the First Trimester: Relationship with Maternal Factors and Placental Doppler Studies

Overview
Date 2010 Jan 7
PMID 20052659
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Placental growth factor (PlGF) is a potent angiogenic factor that impacts on early placental vascular development. It was our aim to clarify relationships between PlGF and first-trimester maternal/placental factors that are related to placental development.

Methods: Prospectively enrolled patients at 11-14 weeks' gestation had serum PlGF measurement by enzyme-linked immunosorbent assay. Results were related to maternal age, parity, race, body mass index, mean arterial blood pressure (MAP), smoking/caffeine use and parameters of placental blood flow resistance.

Results: In 110 consecutive patients PlGF levels ranged between 1.0 and 176.1 pg/mL, showing a linear relationship with gestational age (GA) (PlGF = (1.4251 x GA) -74.951, r(2) = 0.0765, F = 8.941, P = 0.03). PlGF did not relate to maternal demographics but negatively correlated with MAP (Spearman rho = -0.191, P < 0.05). Bilateral uterine artery notching was associated with lower PlGF (40.7 (range, 1.01-131.6) vs. 51.1 (range, 6.4-176.1) pg/mL; Mann-Whitney P = 0.034.). A trend to lower levels was also observed when umbilical artery end-diastolic flow was absent (37.1 (range, 6.8-95) vs. 49.3 (range, 1.01-176.1) pg/mL; P = 0.05).

Conclusion: PlGF in the first trimester is related to maternal cardiovascular factors and placental Doppler findings that are associated with subsequent placental dysfunction. The utility of this parameter as a first-trimester screening tool on a population basis requires further investigation.

Citing Articles

Maternal dietary patterns and placental outcomes among pregnant women in Los Angeles.

Meng Q, Del Rosario I, Sung K, Janzen C, Devaskar S, Carpenter C Placenta. 2023; 145:72-79.

PMID: 38100961 PMC: 11419549. DOI: 10.1016/j.placenta.2023.12.002.


Behavior of the Genetic Markers at Screening during the First Trimester of Pregnancy in Euploid Fetuses.

Romero Infante X, Uriel M, Gutierrez A, Hernandez M, Hernandez A, Jimenez L Rev Bras Ginecol Obstet. 2022; 44(7):646-653.

PMID: 35667377 PMC: 9948148. DOI: 10.1055/s-0042-1744461.


High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.

Beck C, Allshouse A, Silver R, Grobman W, Simhan H, Haas D Am J Obstet Gynecol MFM. 2022; 4(3):100614.

PMID: 35283347 PMC: 9097796. DOI: 10.1016/j.ajogmf.2022.100614.


Administration of recombinant human placental growth factor decreases blood pressure in obese hypertensive pregnant rats.

Palei A, Y Tan A, Joo W, Kussie P, Anderson C, Wilson B J Hypertens. 2020; 38(11):2295-2304.

PMID: 32618892 PMC: 7544658. DOI: 10.1097/HJH.0000000000002528.


In vivo evidence of significant placental growth factor release by normal pregnancy placentas.

Cerdeira A, Kandzija N, Pargmae P, Tome M, Zhang W, Cooke W Sci Rep. 2020; 10(1):132.

PMID: 31924819 PMC: 6954247. DOI: 10.1038/s41598-019-56906-w.